Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in India, for $12 billion. Sun Pharma acquisitions expand the buyer’s global footprint in healthcare, while Organon’s pharmacy capabilities strengthen its branded and specialty drug portfolio across international markets. Organon brings manufacturing and commercial infrastructure that supports Sun Pharma’s platform acquisition strategy and strategic acquisition of scale in multiple countries. The strategic acquisition is announced as a platform acquisition and valued at $12.5 billion, with completion anticipated in early 2027 and combined revenue projected around $12.5 billion.